Literature DB >> 19164854

Effects of Schwann cell transplants in an experimental nerve amputee model.

Natalia Lago1, Caty Casas, Elizabeth M Muir, John Rogers, Xavier Navarro.   

Abstract

PURPOSE: By using a nerve amputee model of the rat sciatic nerve (Lago and Navarro, 2007), we have tested a strategy for the long-term maintenance of regenerated axons without distal target reinnervation, by grafting Schwann cells (SCs) into a capped silicone chamber containing the ending nerve stump.
METHODS: The sciatic nerve of rats was transected and repaired with a silicone tube, the distal nerve was again cut at 10 mm and inserted in a capped tube that was filled with saline or with a suspension of cultured SCs. Transplants of SCs obtained from primary cultures have been compared with those of an immortalized SC line (SCTM41) or the same line overexpressing GDNF.
RESULTS: The histological results show that nerve fibers were able to regenerate through a short distal nerve segment ending into the capped chamber, and sustain distal branches without degenerating for several months. There was abundant axonal sprouting forming an ending neuroma, and the caliber of myelinated fibers remained far thinner than normal during the 9 months investigated. With a distal transplant of primary SCs there were significantly more regenerated myelinated fibers than in the control group at 9 months, indicating that the grafted cells stimulated the axonal growth response and helped to maintain survival of axon branches. In contrast, axonal regeneration was significantly reduced with grafts of SCTM41 cells, probably due to physical competition between cell proliferation and axonal growth. SCTM41 cells overexpressing GDNF improved the regenerative response with respect to the parent SCTM41 cells, although not to the same extent as the primary SCs.
CONCLUSION: A graft of primary SCs in the capped chamber stimulated axonal growth response and/or maintained survival of axonal branches on the long term in the nerve amputee model.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19164854     DOI: 10.3233/RNN-2009-0462

Source DB:  PubMed          Journal:  Restor Neurol Neurosci        ISSN: 0922-6028            Impact factor:   2.406


  5 in total

1.  c-Jun gene-modified Schwann cells: upregulating multiple neurotrophic factors and promoting neurite outgrowth.

Authors:  Liangliang Huang; Xin Quan; Zhongyang Liu; Teng Ma; Yazhen Wu; Jun Ge; Shu Zhu; Yafeng Yang; Liang Liu; Zhen Sun; Jinghui Huang; Zhuojing Luo
Journal:  Tissue Eng Part A       Date:  2015-04       Impact factor: 3.845

2.  Nerve allografts supplemented with schwann cells overexpressing glial-cell-line-derived neurotrophic factor.

Authors:  Katherine B Santosa; Nithya J Jesuraj; Andreu Viader; Matthew MacEwan; Piyaraj Newton; Daniel A Hunter; Susan E Mackinnon; Philip J Johnson
Journal:  Muscle Nerve       Date:  2012-11-21       Impact factor: 3.217

3.  A magnetically responsive nanocomposite scaffold combined with Schwann cells promotes sciatic nerve regeneration upon exposure to magnetic field.

Authors:  Zhongyang Liu; Shu Zhu; Liang Liu; Jun Ge; Liangliang Huang; Zhen Sun; Wen Zeng; Jinghui Huang; Zhuojing Luo
Journal:  Int J Nanomedicine       Date:  2017-10-24

4.  Stem cells in end-to-side neurorrhaphy. Experimental study in rats.

Authors:  Geruza Rezende Paiva; Fausto Viterbo; Elenice Deffune; Maria Aparecida Domingues Custódio
Journal:  Acta Cir Bras       Date:  2021-01-20       Impact factor: 1.388

5.  Schwann cells overexpressing FGF-2 alone or combined with manual stimulation do not promote functional recovery after facial nerve injury.

Authors:  Kirsten Haastert; Maria Grosheva; Srebrina K Angelova; Orlando Guntinas-Lichius; Emmanouil Skouras; Joern Michael; Claudia Grothe; Sarah A Dunlop; Doychin N Angelov
Journal:  J Biomed Biotechnol       Date:  2009-10-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.